Evidence map›Paper›PMID 36978977›Full record

ArticleAntioxidants (Basel, Switzerland)2023

Increased Renal Medullary NOX-4 in Female but Not Male Mice during the Early Phase of Type 1 Diabetes: Potential Role of ROS in Upregulation of TGF-β1 and Fibronectin in Collecting Duct Cells.

Felipe Casado-Barragán, Geraldine Lazcano-Páez, Paulina E Larenas, Monserrat Aguirre-Delgadillo, Fernanda Olivares-Aravena, Daniela Witto-Oyarce, Camila Núñez-Allimant, Katherin Silva, Quynh My Nguyen, Pilar Cárdenas and 2 more

Open access · goldFull text read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Felipe Casado-BarragánInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Geraldine Lazcano-PáezInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Paulina E LarenasInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Monserrat Aguirre-DelgadilloInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Fernanda Olivares-AravenaInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Daniela Witto-OyarceInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Camila Núñez-AllimantInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Katherin SilvaInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.ORCID 0009-0000-4538-9492
Quynh My NguyenSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.
Pilar CárdenasInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.
Modar KassanCollege of Dental Medicine, Lincoln Memorial University, Knoxville, TN 37917, USA.ORCID 0000-0002-9728-063X
Alexis A GonzalezInstitute of Chemisry, Pontificia Universidad Católica de Valparaíso, Valparaíso 2950, Chile.ORCID 0000-0003-0323-1448
Pontificia Universidad Católica de Valparaíso · CLLincoln Memorial University · USUniversity of California San Diego · US

Funding

Agencia Nacional de Investigación y Desarrollo FONDECYT 1220525
6 · The paper itself

Abstract

Chronic diabetes mellitus (DM) can lead to kidney damage associated with increased reactive oxygen species (ROS), proteinuria, and tubular damage. Altered protein expression levels of transforming growth factor-beta 1 (TGF-β1), fibronectin, and renal NADPH oxidase (NOX-4) are associated with the profibrotic phenotype in renal tubular cells. NOX-4 is one of the primary sources of ROS in the diabetic kidney and responsible for the induction of profibrotic factors in collecting duct (CD) cells. The renal medulla is predominantly composed of CDs; in DM, these CD cells are exposed to high glucose (HG) load. Currently there is no published literature describing the expression of these markers in the renal medulla in male and female mice during the early phase of DM, or the role of NOX-4-induced ROS. Our aim was to evaluate changes in transcripts and protein abundances of TGF-β1, fibronectin, and NOX-4 along with ROS levels in renal medullary tissues from male and female mice during a short period of streptozotocin (STZ)-induced type 1 DM and the effect of HG in cultured CD cells. CF-1 mice were injected with or without a single dose of STZ (200 mg/kg) and euthanized at day 6. STZ females showed higher expression of fibronectin and TGF-β1 when compared to control mice of either gender. Interestingly, STZ female mice showed a >30-fold increase on mRNA levels and a 3-fold increase in protein levels of kidney medullary NOX-4. Both male and female STZ mice showed increased intrarenal ROS. In primary cultures of inner medullary CD cells exposed to HG over 48 h, the expression of TGF-β1, fibronectin, and NOX-4 were augmented. M-1 CD cells exposed to HG showed increased ROS, fibronectin, and TGF-β1; this effect was prevented by NOX-4 inhibition. Our data suggest that at as early as 6 days of STZ-induced DM, the expression of profibrotic markers TGF-β1 and fibronectin increases in renal medullary CD cells. Antioxidants mechanisms in male and female in renal medullary tissues seems to be differentially regulated by the actions of NOX-4.

Indexed as

diabetesfibrotic factorsmiceROSsex differences

Identifiers

PMID36978977
PMCPMC10045926
OpenAlexW4327596677

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read29
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.